123 related articles for article (PubMed ID: 23396845)
41. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.
von Bohlen und Halbach O; Minichiello L; Unsicker K
FASEB J; 2005 Oct; 19(12):1740-2. PubMed ID: 16037097
[TBL] [Abstract][Full Text] [Related]
42. AKAP13-NTRK3: A novel NTRK3 oncogenic fusion variant in a patient with melanoma.
Wei D; Qi C; Wu Y; Zhang X; Ren G
Oral Oncol; 2020 Dec; 111():104891. PubMed ID: 32654869
[No Abstract] [Full Text] [Related]
43. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm.
Tauszig-Delamasure S; Yu LY; Cabrera JR; Bouzas-Rodriguez J; Mermet-Bouvier C; Guix C; Bordeaux MC; Arumäe U; Mehlen P
Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13361-6. PubMed ID: 17686986
[TBL] [Abstract][Full Text] [Related]
44. In retinitis pigmentosa TrkC.T1-dependent vectorial Erk activity upregulates glial TNF-α, causing selective neuronal death.
Galán A; Jmaeff S; Barcelona PF; Brahimi F; Sarunic MV; Saragovi HU
Cell Death Dis; 2017 Dec; 8(12):3222. PubMed ID: 29242588
[TBL] [Abstract][Full Text] [Related]
45. Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cells.
Sekimoto M; Tsuji T; Matsuzaki J; Chamoto K; Koda T; Nemoto K; Degawa M; Nishimura S; Nishimura T
Immunol Lett; 2003 Sep; 88(3):221-6. PubMed ID: 12941481
[TBL] [Abstract][Full Text] [Related]
46. Proprioceptive afferents survive in the masseter muscle of trkC knockout mice.
Matsuo S; Ichikawa H; Silos-Santiago I; Arends JJ; Henderson TA; Kiyomiya K; Kurebe M; Jacquin MF
Neuroscience; 2000; 95(1):209-16. PubMed ID: 10619477
[TBL] [Abstract][Full Text] [Related]
47. [ShcD interacts with TrkC through its PTB and SH2 domains].
You YG; Li WQ; Yin B; Peng XZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Dec; 31(6):720-3. PubMed ID: 20078941
[TBL] [Abstract][Full Text] [Related]
48. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
[TBL] [Abstract][Full Text] [Related]
49. Genetic evidence for selective neurotrophin 3 signalling through TrkC but not TrkB in vivo.
Stenqvist A; Agerman K; Marmigère F; Minichiello L; Ernfors P
EMBO Rep; 2005 Oct; 6(10):973-8. PubMed ID: 16142215
[TBL] [Abstract][Full Text] [Related]
50. Interferon-β Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor.
Dedoni S; Olianas MC; Ingianni A; Onali P
Mol Neurobiol; 2017 Apr; 54(3):1825-1843. PubMed ID: 26887385
[TBL] [Abstract][Full Text] [Related]
51. Refractory infantile high-grade glioma containing TRK-fusion responds to larotrectinib.
Waters TW; Moore SA; Sato Y; Dlouhy BJ; Sato M
Pediatr Blood Cancer; 2021 May; 68(5):e28868. PubMed ID: 33403813
[No Abstract] [Full Text] [Related]
52. Haploinsufficiency in trkB and/or trkC neurotrophin receptors causes structural alterations in the aged hippocampus and amygdala.
von Bohlen und Halbach O; Minichiello L; Unsicker K
Eur J Neurosci; 2003 Oct; 18(8):2319-25. PubMed ID: 14622193
[TBL] [Abstract][Full Text] [Related]
53. Ontogenetic expression of trk neurotrophin receptors in the chick auditory system.
Cochran SL; Stone JS; Bermingham-McDonogh O; Akers SR; Lefcort F; Rubel EW
J Comp Neurol; 1999 Oct; 413(2):271-88. PubMed ID: 10524339
[TBL] [Abstract][Full Text] [Related]
54. Differential regulation of the expression of neurotrophin receptors in rat extraocular motoneurons after lesion.
Morcuende S; Matarredona ER; Benítez-Temiño B; Muñoz-Hernández R; Pastor AM; de la Cruz RR
J Comp Neurol; 2011 Aug; 519(12):2335-52. PubMed ID: 21456016
[TBL] [Abstract][Full Text] [Related]
55. TrkB and TrkC are differentially regulated by excitotoxicity during development of the basal ganglia.
Checa N; Canals JM; Gratacòs E; Alberch J
Exp Neurol; 2001 Dec; 172(2):282-92. PubMed ID: 11716553
[TBL] [Abstract][Full Text] [Related]
56. Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.
Wood LD; Calhoun ES; Silliman N; Ptak J; Szabo S; Powell SM; Riggins GJ; Wang TL; Yan H; Gazdar A; Kern SE; Pennacchio L; Kinzler KW; Vogelstein B; Velculescu VE
Hum Mutat; 2006 Oct; 27(10):1060-1. PubMed ID: 16941478
[TBL] [Abstract][Full Text] [Related]
57. Expression of tyrosine kinase receptor C in the segments of the spinal cord and the cerebral cortex after cord transection in adult rats.
Qian DX; Zhang HT; Cai YQ; Luo P; Xu RX
Neurosci Bull; 2011 Apr; 27(2):83-90. PubMed ID: 21441969
[TBL] [Abstract][Full Text] [Related]
58. Role of neurotropins in rat embryonic testis morphogenesis (cord formation).
Levine E; Cupp AS; Skinner MK
Biol Reprod; 2000 Jan; 62(1):132-42. PubMed ID: 10611077
[TBL] [Abstract][Full Text] [Related]
59. Neurotrophins and Trk receptors in primitive neuroectodermal tumor cell lines.
Chiappa SA; Chin LS; Zurawel RH; Raffel C
Neurosurgery; 1999 Nov; 45(5):1148-54; discussion 1154-5. PubMed ID: 10549931
[TBL] [Abstract][Full Text] [Related]
60. Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma.
Seo E; Kim JS; Ma YE; Cho HW; Ju HY; Lee SH; Lee JW; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2019 Oct; 34(39):e254. PubMed ID: 31602824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
